Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript November 8, 2023
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.02, expectations were $0.68.
Operator: Thank you for standing by. My name is Danika and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Ligand Third Quarter 2023 Earnings Webcast. All lines have been placed on mute to prevent any background noise. After the speakers’...
